1. Home
  2. BDTX vs MIN Comparison

BDTX vs MIN Comparison

Compare BDTX & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • MIN
  • Stock Information
  • Founded
  • BDTX 2014
  • MIN 1988
  • Country
  • BDTX United States
  • MIN United States
  • Employees
  • BDTX N/A
  • MIN N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • BDTX Health Care
  • MIN Finance
  • Exchange
  • BDTX Nasdaq
  • MIN Nasdaq
  • Market Cap
  • BDTX 292.0M
  • MIN 301.0M
  • IPO Year
  • BDTX 2020
  • MIN N/A
  • Fundamental
  • Price
  • BDTX $5.95
  • MIN $2.66
  • Analyst Decision
  • BDTX Strong Buy
  • MIN
  • Analyst Count
  • BDTX 3
  • MIN 0
  • Target Price
  • BDTX $13.00
  • MIN N/A
  • AVG Volume (30 Days)
  • BDTX 842.2K
  • MIN 331.0K
  • Earning Date
  • BDTX 08-09-2024
  • MIN 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • MIN 7.31%
  • EPS Growth
  • BDTX N/A
  • MIN N/A
  • EPS
  • BDTX N/A
  • MIN 0.08
  • Revenue
  • BDTX N/A
  • MIN N/A
  • Revenue This Year
  • BDTX N/A
  • MIN N/A
  • Revenue Next Year
  • BDTX N/A
  • MIN N/A
  • P/E Ratio
  • BDTX N/A
  • MIN $33.38
  • Revenue Growth
  • BDTX N/A
  • MIN N/A
  • 52 Week Low
  • BDTX $1.62
  • MIN $2.52
  • 52 Week High
  • BDTX $7.66
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 62.47
  • MIN 49.03
  • Support Level
  • BDTX $4.28
  • MIN $2.68
  • Resistance Level
  • BDTX $6.28
  • MIN $2.73
  • Average True Range (ATR)
  • BDTX 0.39
  • MIN 0.03
  • MACD
  • BDTX 0.18
  • MIN -0.00
  • Stochastic Oscillator
  • BDTX 84.51
  • MIN 36.66

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: